Formulation Development of Extended Released Rifaximin Micro-particles - Couverture souple

Bhise Kiran; Karanje Rohan

 
9783659418402: Formulation Development of Extended Released Rifaximin Micro-particles

Synopsis

This book addresses the formulation and process design aspects of extended release micro particles of BCS class IV drug Rifaximin through cyclodextrin complexation and extending the drug release by Eudragit L -100 enteric coating. The concept of surface response methodology was used in the selection of optimized batch that was further evaluated for various parameters. The data supports an improvement in aqueous solubility of BCS class IV drugs through cyclodextrin complexes. The release of such inclusion complexes can be retarded for 8 hrs by enteric coating.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.